Investigator Kristin takes a hands-on approach during his audits by focusing intensively on the cleanliness and safety of the production environment. He emphasizes the utilization of correct containment and proper cleaning agents to reduce the risk of cross-contamination and to ensure the safety and quality of the drug production.

Investigator Kristin M Abaonza appears to show a specific interest in cleanliness, contamination prevention, and appropriate usage of pharmaceutical-grade components during drug production. It seems that he is diligent and thorough in ensuring that the production environments and methods adhere to industry standards. He prioritizes the quality of cleanliness agents and the right containment for different product types, emphasizing the necessity of upholding the sanitation standards to prevent cross-contamination risks.